268 related articles for article (PubMed ID: 19160092)
1. p53 Mutations in carcinoma of the esophagus and gastroesophageal junction.
Sengpiel C; König IR; Rades D; Noack F; Duchrow M; Schild SE; Ludwig D; Homann N
Cancer Invest; 2009 Jan; 27(1):96-104. PubMed ID: 19160092
[TBL] [Abstract][Full Text] [Related]
2. P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus.
Schneider PM; Stoeltzing O; Roth JA; Hoelscher AH; Wegerer S; Mizumoto S; Becker K; Dittler HJ; Fink U; Siewert JR
Clin Cancer Res; 2000 Aug; 6(8):3153-8. PubMed ID: 10955797
[TBL] [Abstract][Full Text] [Related]
3. p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer.
Makino T; Yamasaki M; Miyata H; Yoshioka S; Takiguchi S; Fujiwara Y; Nakajima K; Nishida T; Mori M; Doki Y
Ann Surg Oncol; 2010 Mar; 17(3):804-11. PubMed ID: 19885698
[TBL] [Abstract][Full Text] [Related]
4. p53 mutations in head and neck cancer: new data and evaluation of mutational spectra.
Olshan AF; Weissler MC; Pei H; Conway K
Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):499-504. PubMed ID: 9232336
[TBL] [Abstract][Full Text] [Related]
5. p53 mutational spectrum of esophageal carcinomas from five different geographical locales in China.
Lung ML; Chan WC; Zong YS; Tang CM; Fok CL; Wong KT; Chan LK; Lau KW
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):277-84. PubMed ID: 8722219
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus].
Schneider PM; Hölscher AH; Wegerer S; König U; Becker K; Siewert JR
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):495-9. PubMed ID: 14518305
[TBL] [Abstract][Full Text] [Related]
7. [Profile of p53 mutations and abnormal expression of P53 protein in 2 forms of esophageal cancer].
Muzeau F; Fléjou JF; Potet F; Belghiti J; Thomas G; Hamelin R
Gastroenterol Clin Biol; 1996; 20(5):430-7. PubMed ID: 8761140
[TBL] [Abstract][Full Text] [Related]
8. p53 genotype predicts response to chemotherapy in patients with squamous cell carcinoma of the esophagus.
Yamasaki M; Miyata H; Fujiwara Y; Takiguchi S; Nakajima K; Nishida T; Yasuda T; Matsuyama J; Mori M; Doki Y
Ann Surg Oncol; 2010 Feb; 17(2):634-42. PubMed ID: 19941080
[TBL] [Abstract][Full Text] [Related]
9. p53 in epidermoid cancer of the esophagus.
Tanaka M; Nonogaki S; Alberti VN; Forones NM
Hepatogastroenterology; 1999; 46(27):1765-8. PubMed ID: 10430340
[TBL] [Abstract][Full Text] [Related]
10. p53 mutations in esophageal tumors from a high incidence area of China in relation to patient diet and smoking history.
Bennett WP; von Brevern MC; Zhu SM; Bartsch H; Muehlbauer KR; Hollstein MC
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):963-6. PubMed ID: 9367071
[TBL] [Abstract][Full Text] [Related]
11. p53 Gene mutation and genetic instability in superficial multifocal esophageal squamous cell carcinoma.
Fujiki T; Haraoka S; Yoshioka S; Ohshima K; Iwashita A; Kikuchi M
Int J Oncol; 2002 Apr; 20(4):669-79. PubMed ID: 11894109
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective study.
Casson AG; Evans SC; Gillis A; Porter GA; Veugelers P; Darnton SJ; Guernsey DL; Hainaut P
J Thorac Cardiovasc Surg; 2003 May; 125(5):1121-31. PubMed ID: 12771886
[TBL] [Abstract][Full Text] [Related]
13. Mutational spectra of p53 in geographically localized esophageal squamous cell carcinoma groups in China.
Cao W; Chen X; Dai H; Wang H; Shen B; Chu D; McAfee T; Zhang ZF
Cancer; 2004 Aug; 101(4):834-44. PubMed ID: 15305417
[TBL] [Abstract][Full Text] [Related]
14. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status.
Wu JY; Wang J; Lai JC; Cheng YW; Yeh KT; Wu TC; Chen CY; Lee H
Ann Surg Oncol; 2008 Nov; 15(11):3272-7. PubMed ID: 18712569
[TBL] [Abstract][Full Text] [Related]
15. Primary squamous cell carcinoma of the stomach: a case report with immunohistochemical and molecular biologic studies.
Takita J; Kato H; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Manda R; Fukuchi M; Kuwano H
Hepatogastroenterology; 2005; 52(63):969-74. PubMed ID: 15966243
[TBL] [Abstract][Full Text] [Related]
16. Comparison of p53 mutations between adenocarcinoma and squamous cell carcinoma of the lung: unique spectra involving G to A transitions and G to T transversions in both histologic types.
Gao WM; Mady HH; Yu GY; Siegfried JM; Luketich JD; Melhem MF; Keohavong P
Lung Cancer; 2003 May; 40(2):141-50. PubMed ID: 12711114
[TBL] [Abstract][Full Text] [Related]
17. Detection of p53 gene mutations in human esophageal squamous cell carcinomas using a p53 yeast functional assay: possible difference in esophageal carcinogenesis between the young and the elderly group.
Okuda E; Osugi H; Morimura K; Takada N; Takemura M; Fukushima S; Higashino M; Kinoshita H
Clin Cancer Res; 2001 Mar; 7(3):600-6. PubMed ID: 11297255
[TBL] [Abstract][Full Text] [Related]
18. Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Resetkova E; Wang H; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Hamilton SR; Albarracin CT
Clin Cancer Res; 2006 Aug; 12(15):4598-604. PubMed ID: 16899607
[TBL] [Abstract][Full Text] [Related]
19. Gene mutations and polymorphisms of TP53 and FHIT in chronic esophagitis and esophageal carcinoma.
Silveira AP; Da Silva Manoel-Caetano F; Aoki S; Yamasaki LH; Rahal P; Silva AE
Anticancer Res; 2011 May; 31(5):1685-90. PubMed ID: 21617227
[TBL] [Abstract][Full Text] [Related]
20. Distribution of p53 mutations in esophageal and gastric carcinomas and the relationship with p53 expression.
Hanazono K; Natsugoe S; Stein HJ; Aikou T; Hoefler H; Siewert JR
Oncol Rep; 2006 Apr; 15(4):821-4. PubMed ID: 16525665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
